| ¿µ¹® | blood group | ÇÑ±Û | Ç÷¾×Çü |
|---|---|---|---|
| ¼³¸í | »ç¶÷ÀÇ ÀûÇ÷±¸ Ç¥¸é¿¡´Â ¿©·¯ °¡Áö Ç׿ø¼ºÀ» °¡Áø ¹°ÁúÀÌ Á¸ÀçÇÑ´Ù. Áï ¸é¿ªÇÐÀû ¹ÝÀÀÀ» ÀÏÀ¸Å³ ¼ö ÀÖ´Â ¹°ÁúÀ» Ç¥¸é¿¡ °¡Áö°í ÀÖ´Ù. ±×¸®°í »ç¶÷ÀÇ ÇǼӿ¡´Â À̰Ͱú ¹ÝÀÀÇÒ ¼ö°¡ ÀÖ´Â Ç×üµµ Á¸ÀçÇÑ´Ù. »ç¶÷ÀÇ Ç÷¾×Àº À̰Ϳ¡ µû¶ó ¸î°¡Áö ÇüÀ¸·Î ºÐ·ùÇÒ ¼ö°¡ ÀÖ°í, À̰ÍÀ» Ç÷¾×ÇüÀ̶ó°í ÇÑ´Ù. Ç÷¾×ÇüÀº ÀûÇ÷±¸ Ç¥¸é¿¡ ÀÖ´Â ¾î¶² ¹°ÁúÀ» ±âÁØÀ¸·Î ÇÏ´À³Ä¿¡ µû¶ó¼ ¿©·¯ °¡Áö·Î ºÐ·ùµÉ ¼ö ÀÖ´Ù. ´ëÇ¥ÀûÀÎ Ç÷¾×ÇüÀÇ ±¸ºÐ ¹æ¹ý¿¡´Â ABOÇ÷¾×Çü°ú RhÇ÷¾×ÇüÀÌ ÀÖ´Ù. 1. ABO Ç÷¾×Çü °¡Àå ¸¹ÀÌ »ç¿ëµÇ°í ÀÖ´Â Ç÷¾×Çü ±¸ºÐ¹ý. ÀûÇ÷±¸ Ç¥¸é¿¡´Â A, BÇüÀÇ µÎ °¡Áö ¹°ÁúÀ» Çϳª, ȤÀº µÑ, ¶Ç´Â Çϳªµµ °¡ÁöÁö ¾ÊÀ» ¼ö°¡ ÀÖ´Ù. ±×¸®°í ÇǼӿ¡´Â À̰Ͱú ¹ÝÀÀÇØ¼ ÀûÇ÷±¸¸¦ ÆÄ±«Çϰųª ÀÀÁý½Ãų ¼ö ÀÖ´Â ¹°Áú(Ç×ü)ÀÌ Á¸ÀçÇÑ´Ù. ¹°·Ð ÀÚ½ÅÀÇ ÀûÇ÷±¸°¡ °¡Áö°í ÀÖ´Â ¹°Áú¿¡ ´ëÇÑ Ç×ü´Â Á¸ÀçÇÏÁö ¾Ê´Â´Ù. -AÇü Ç÷¾×Çü£ÀûÇ÷±¸ Ç¥¸é¿¡ AÇ׿ø, Ç÷¾×¼Ó¿¡ B¿¡ ´ëÇÑ Ç×ü -BÇü Ç÷¾×Çü£ÀûÇ÷±¸ Ç¥¸é¿¡ BÇ׿ø, Ç÷¾×¼Ó¿¡ A¿¡ ´ëÇÑ Ç×ü -ABÇü Ç÷¾×Çü£ÀûÇ÷±¸ Ç¥¸é¿¡ A, BÇ׿ø, Ç÷¾×¼Ó¿¡ A,B¿¡ ´ëÇÑ Ç×ü¸¦ °¡ÁöÁö ¾Ê´Â´Ù. -OÇü Ç÷¾×Çü£ÀûÇ÷±¸ Ç¥¸é¿¡ A, BÇ׿ø ¸ðµÎ¸¦ °¡ÁöÁö ¾Ê°í, Ç÷¾×¼Ó¿¡ A, B¿¡ ´ëÇÑ Ç׿øÀ» ¸ðµÎ °¡Áø´Ù. ´ë°³ À̰ÍÀ» ÀÌ¿ëÇÏ¿© ¼öÇ÷ÀÇ Å¸´ç¼º ¿©ºÎ¸¦ Á¶»çÇÑ´Ù. ¸¸¾à AÇü Ç÷¾×ÇüÀ» °¡Áø »ç¶÷ÀÇ ÇǸ¦ BÇü Ç÷¾×ÇüÀÇ »ç¶÷¿¡°Ô ¼öÇ÷Çϸé BÇü Ç÷¾×ÇüÀ» °¡Áø ÀÚÀÇ ÇǼӿ¡ ÀÖ´Â A¿¡ ´ëÇÑ Ç×ü¶§¹®¿¡ µé¾î¿Â AÇüÀÇ ÀûÇ÷±¸´Â ÆÄ±«µÇ°Å³ª, ÀÀÁýÀÌ µÈ´Ù. OÇüÀÇ Ç÷¾×ÇüÀ» °¡Áø »ç¶÷ÀÇ Ç÷¾×ÀÇ ÀûÇ÷±¸´Â Ç¥¸é¿¡ A, BÀÇ ¾î¶°ÇÑ ¹°Áúµµ °¡Áö°í ÀÖÁö ¾Ê¾Æ¼ ¾î¶°ÇÑ Ç÷¾×ÇüÀ» °¡Áø »ç¶÷¿¡°Ô ¼öÇ÷ÇØµµ ¹ÝÀÀÀ» ÀÏÀ¸Å°Áö ¾Ê´Â´Ù. ÀÌ¿Í °°Àº ¿ø¸®·Î ABÇüÀÇ Ç÷¾×ÇüÀ» °¡Áø »ç¶÷Àº Ç÷¾×¼Ó¿¡ A, B¿¡ ´ëÇÑ Ç×ü¸¦ ¸ðµÎ °¡Áö°í ÀÖÁö ¾ÊÀ¸¹Ç·Î ¾î¶°ÇÑ Ç÷¾×ÇüÀÌ¶óµµ ¹ÞÀ» ¼ö°¡ ÀÖ´Ù. 2. RhÇ÷¾×Çü ÀûÇ÷±¸Ç¥¸é¿¡ ÀÖ´Â D¶ó´Â ¹°ÁúÀ» ±âÁØÀ¸·Î ÇÏ¿© Ç÷¾×ÇüÀ» ³ª´©´Â ¹æ¹ý. ¸¸¾à D¶ó´Â ¹°ÁúÀÌ ÀûÇ÷±¸ÀÇ Ç¥¸é¿¡ Á¸ÀçÇϸé Rh(+), Á¸ÀçÇÏÁö ¾ÊÀ¸¸é Rh(£)¶ó°í ÇÑ´Ù. ABOÇ÷¾×Çü¿¡¼¿Í °°ÀÌ Rh(+)Ç÷¾×ÇüÀ» °¡Áö´Â »ç¶÷ÀÇ ÇǼӿ¡´Â D¶ó´Â ¹°Áú¿¡ ´ëÇÑ Ç×ü°¡ Á¸ÀçÇÏÁö ¾ÊÁö¸¸ Rh(£)Ç÷¾×ÇüÀ» °¡Áø »ç¶÷ÀÇ ÇǼӿ¡´Â D¿¡ ´ëÇÑ Ç×ü°¡ Á¸ÀçÇÑ´Ù. ABOÇ÷¾×Çü°ú ¸¶Âù°¡Áö·Î ¼öÇ÷ÀÇ Å¸´ç¼ºÀ» °áÁ¤Çϴµ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÑ´Ù. |
||
| ¿µ¹® | blood clotting, blood coagulation | ÇÑ±Û | Ç÷¾×ÀÀ°í |
|---|---|---|---|
| ¼³¸í | »ç¶÷ÀÇ ¸ö¿¡ »óó°¡ ³ª¼ ÃâÇ÷ÀÌ ÀÖÀ» °æ¿ì¿¡ À̰ÍÀ» ¸·°í ÇǸ¦ ´õÀÌ»ó ³ªÁö ¾Ê°Ô ÇÏ´Â °ÍÀ» ÁöÇ÷À̶ó°í ÇÑ´Ù. ÁöÇ÷ÀÇ °úÁ¤¿¡´Â Å©°Ô µÎ °¡Áö ´Ü°è°¡ ÀÖ´Ù. ù¹øÂ° ´Ü°è´Â Ç÷¼ÒÆÇµéÀÌ »óó°¡ ³ª¼ ¼Õ»óµÈ Ç÷°üÀÇ ºÎÀ§¸¦ ¸·´Â °ÍÀÌ´Ù. ÀÌ·¸°Ô ÇÏ¸é ¿ì¼± Ç÷°üÀÇ ¼Õ»óºÎÀ§·Î ºÎÅÍ Çǰ¡ ³ª¿À´Â °ÍÀ» ¸·À» ¼ö°¡ ÀÖ´Ù. ´ÙÀ½ÀÇ ´Ü°è´Â »óó¸¦ ¸·°í ÀÖ´Â Ç÷¼ÒÆÇÀ§¿¡ ¿©·¯ °¡Áö ¹°ÁúµéÀÌ ÀÛ¿ëÇØ¼ ´õ¿í ´Ü´ÜÇÏ°Ô ÇÏ¿© »óó°¡ ³ Ç÷°ü¿¡¼ Çǰ¡ »õ´Â °ÍÀ» ¿µ±¸È÷ ¸·´Â °ÍÀÌ´Ù. ½±°Ô ¸»Çϸé Ç÷¼ÒÆÇÀº º®µ¹¿¡ ÇØ´çÇÏ´Â °ÍÀÌ°í µÎ¹øÂ° °úÁ¤¿¡ Âü¿©ÇÏ´Â ¹°ÁúµéÀº ½Ã¸àÆ®¿¡ ÇØ´çÇÏ´Â °ÍÀÌ´Ù. ÀÌ µÎ °úÁ¤ÀÌ ¿ÏÀüÇÒ °æ¿ì¿¡ ÁöÇ÷ÀÌ ¼øÁ¶·Ó°Ô ÀϾÙ. Ç÷¾×ÀÀ°í¶õ µÎ¹øÂ° ´Ü°è¸¦ ÁöĪÇÏ´Â ¸»·Î½á ¸Å¿ì º¹ÀâÇÑ ´Ü°è¸¦ °ÅÄ¡´Â ¹ÝÀÀÀ¸·Î ¸¶Áö¸· ´Ü°è´Â ¼¶À¯¼Ò¶ó´Â ¹°ÁúÀÌ ¸¸µé¾îÁ®¼ ÀÌ ¹°ÁúÀÌ Ç÷¼ÒÆÇ°ú ±× ¿ÜÀÇ ¼¼Æ÷¸¦ ´Ü´ÜÇÏ°Ô °íÁ¤½ÃÄÑ Çǰ¡ »óó³ Ç÷°üÀ¸·Î »õ´Â °ÍÀ» ¸·´Â´Ù. À̰ÍÀ» °¡Àå °£´ÜÈ÷ ¼³¸íÇÏÀÚ¸é Å©°Ô ´ÙÀ½°ú °°Àº 3°¡Áö ´Ü°è·Î ÀÌ·ç¾îÁø´Ù. ù¹øÂ° ´Ü°è´Â Ç÷°ü¼Õ»ó¿¡ ÀÇÇØ¼ ÇÁ·ÎÆ®·Òºó Ȱ¼ºÁ¦¶ó´Â °ÍÀÌ ¸¸µé¾îÁö´Â ´Ü°èÀÌ´Ù. µÎ¹øÂ° ´Ü°è´Â ÀÌ ÇÁ·ÎÆ®·Òºó Ȱ¼ºÁ¦¶ó´Â ¹°Áú¿¡ ÀÇÇØ¼ Ç÷¾×¼Ó¿¡ ÀÖ´Â ÇÁ·ÎÆ®·ÒºóÀ̶ó´Â ¹°ÁúÀÌ Æ®·ÒºóÀ̶ó´Â ¹°Áú·Î ¹Ù²î´Â ´Ü°èÀÌ´Ù. ¼¼¹øÂ° ´Ü°è´Â Æ®·ÒºóÀ̶ó´Â ¹°Áú¿¡ ÀÇÇØ¼ ¼¶À¯¼Ò¿øÀ̶ó´Â ¹°ÁúÀÌ ¼¶À¯¼ÒÀ¸·Î ¹Ù²î´Â ´Ü°èÀÌ´Ù. |
||
| ¿µ¹® | fasting blood sugar | ÇÑ±Û | °øº¹Ç÷´ç, ºó¼ÓÇ÷´ç |
|---|---|---|---|
| ¼³¸í | Ç÷¾×¼Ó¿¡ Æ÷ÇԵǾî ÀÖ´Â Æ÷µµ´ç. ³ú¿Í ÀûÇ÷±¸ÀÇ ¿¡³ÊÁö¿øÀÌ µÇ°í, ±× ¾çÀº ¿îµ¿, ½Ä»ç µûÀ§¿¡ ÀÇÇÏ¿© ´Þ¶óÁø´Ù. °Ç°ÀÎÀÇ ¾ÆÄ§ °øº¹½Ã Ç÷Áß Æ÷µµ´ç ³óµµ´Â 60~100mg/dLÀÌÁö¸¸ ±âŸÀÇ ´çÁú Áï °ú´ç, °¥¶ôÅ佺, 5ź´çÀº ¹Ì·®À̸ç ÀϹÝÀûÀ¸·Î Ç÷´çÀÏ Çϸé Ç÷Á߯÷µµ´çÀ» ÀǹÌÇÑ´Ù. Ç÷´çÀº »ýüÀÇ ¿¡³ÊÁö¿øÀ¸·Î¼ °¡Àå Áß¿äÇÑ ¹°ÁúÀÌ´Ù. ±× ³óµµ´Â âÀÚ°üÀ¸·ÎºÎÅÍÀÇ Èí¼ö, °£¿¡ ÀÖ¾î¼ÀÇ ´ç½Å»ý°ú ±Û¸®ÄÚ°ÕÀÇ ÇÕ¼º-ºÐÇØ, ¸»ÃÊÁ¶Á÷ÀÇ ´çÀÌ¿ë, ÄáÆÏÀ¸·ÎºÎÅÍÀÇ ¹è¼³ µî ¿©·¯ ÀÎÀÚ¿¡ÀÇÇØ Á¿ìµÇ¸ç ±× Á¶Àý¿¡´Â ÀÚÀ²½Å°æ°ú °¢Á¾ È£¸£¸óÀÌ ¹ÐÁ¢ÇÏ°Ô °ü°èÇÑ´Ù. ƯÈ÷ Ç÷´çÀúÇÏÀÛ¿ë¿¡´Â Àν¶¸°ÀÌ, ±×¸®°í Ç÷´ç»ó½ÂÀÛ¿ë¿¡´Â ¿¡Çdz×ÇÁ¸°, ±Û·çÄ«°ï, ¼ºÀåÈ£¸£¸ó, ºÎ½Å°ÑÁúÈ£¸£¸ó, ºÎ½Å°ÑÁúÀÚ±ØÈ£¸£¸ó, °©»ó»ù È£¸£¸óÀÌ °ü°è°¡ ÀÖÀ¸¸ç ±×°ÍµéÀÇ ´ëÇ× ¹× ÇùÁ¶ ÀÛ¿ë¿¡ ÀÇÇØ Ç÷´çÄ¡°¡ Á¶ÀýµÈ´Ù. |
||
| ¿µ¹® | white blood cell(WBC), leukocyte | ÇÑ±Û | ¹éÇ÷±¸ |
|---|---|---|---|
| ¼³¸í | Ç÷¾×³»¿¡ °ñ¼ö±¸°è¼¼Æ÷¿Í ¸²ÇÁ°è¼¼Æ÷, ´ÜÇÙ±¸°è¼¼Æ÷¸¦ ¸ðµÎ ÅëÆ²¾î ¸»ÇÑ´Ù. ¹éÇ÷±¸ÀÇ Áõ°¡°¡ ÀÖÀ¸¸é ´ë°³ °¨¿°ÀÌ Àְųª, ȤÀº Å»¼öÇö»óÀÌ ÀÖÀ½À» ÀǹÌÇÑ´Ù. ¶ÇÇÑ Áö³ªÄ£ ¹éÇ÷±¸¼öÀÇ °¨¼Ò´Â ÀÎü³» ¸é¿ª±â´ÉÀÌ ¶³¾îÁ® ÀÖÀ½À» ÀǹÌÇϸç, ´Ù¸¥ Áúº´¿¡ ÀÇÇØ ³ªÅ¸³ª´Â ÀÌÂ÷ÀûÀÎ Çö»óÀÌ ¾Æ´ÑÁö ²À Áø´ÜÀ» ¹Þ¾Æº¸¾Æ¾ß ÇÑ´Ù. |
||
| ¿µ¹® | whole blood | ÇÑ±Û | ÀüÇ÷, ¿ÂÇ÷¾× |
|---|---|---|---|
| ¼³¸í | Ç÷¾×ÀÇ ¸ðµç ¼ººÐÀÌ Çϳªµµ Á¦°ÅµÇÁö ¾ÊÀº ¿ÂÀüÇÑ Ç÷¾×. ÀüÇ÷Àº ¾ö°ÝÇÑ ¹«±ÕÁ¶°ÇÇÏ¿¡¼, ¼±º°ÇÑ °øÇ÷ÀڷκÎÅÍ Ã¤ÃëÇÑ °ÍÀ̸ç, ±¸¿¬»ê ÀÌ¿ÂÀ̳ª ÇìÆÄ¸° °°Àº Ç×ÀÀ°øÁ¦·Î ÀÀ°í¸¦ ¹æÁöÇÏ¿© Ç÷¾×º¸Ãæ ¸ñÀûÀ¸·Î »ç¿ëÇÑ´Ù. |
||
| CBV | capillary blood cell velocity; catheter balloon valvuloplasty; central blood volume; cerebral blood ... |
|---|---|
| MN | a blood group in the MNSs blood group system; malignant nephrosclerosis; Master of Nursing; meganewt... |
| CBF | capillary blood flow; cerebral blood flow; ciliary beat frequency; coronary blood flow; cortical blo... |
| HBF | hand blood flow; hemispheric blood flow; hemoglobinuric bilious fever; hepatic blood flow; hypothala... |
| AGPA | American Group Practice Association; American Group Psychotherapy Association |
| C Group | Control group |
|---|---|
| Group C | Group |
| Group 2 | Group 1 |
| group 1 | group B |
| group 3 | group 1 |
Q blood group system
| agglutinins | Substances, usually of biological origin, that cause cells or other organic particles to aggregate and stick to each other. They also include those antibodies which cause aggregation or agglutination of a particulate or insoluble antigen. (12 Dec 1998) |
|---|---|
| warm agglutinins | Antibody that reacts with an antigen that is a normal component of the body. Obviously this can lead to some problems and autoimmunity has been proposed as a causative factor in a number of diseases such as rheumatoid arthritis. See: systemic lupus erythematosus, Hashimoto's thyroiditis, myasthenia gravis. (18 Nov 1997) |
| cold agglutinins | <haematology> Antibodies that agglutinate particles with greater activity below 32C. They are IgM antibodies specifically reactive with blood groups I and i in humans and agglutinate red blood cells on cooling, causing Raynaud's phenomenon in vivo. (18 Nov 1997) |
| wheat germ agglutinins | Lectins purified from the germinating seeds of common wheat (triticum vulgare); these bind to certain carbohydrate moieties on cell surface glycoproteins and are used to identify certain cell populations and inhibit or promote some immunological or physiological activities. There are at least two isoforms of this lectin. (12 Dec 1998) |
| febrile agglutinins | <investigation> A serologic fluorescent antibody screen that indicates infection with the rickettsial bacteria which is responsible for Rocky Mountain spotted fever. This test may also be positive in brucellosis, salmonella infection and tularaemia. (27 Sep 1997) |
| ABO blood group | <haematology> The major human blood type system which describes the oligosaccharide glycoprotein antigens found on the surface of human blood cells. According to the type of antigen present, a person may be assigned a blood type of A, B, AB or O. A second type of antigen, the Rh factor, renders a positive or negative blood type. The ABO blood group system is important because it determines who can donate blood to or accept blood from whom. Type A or AB blood will cause an immune reaction in people with type B blood and type B and AB blood will cause a reaction in people with type A blood. Conversely, type O blood has no A or B antigens, so people with type O blood are universal donors. And since AB blood already produces both antigens, people who are type AB can accept any of the other blood types without suffering an immune reaction. (04 Jul 1999) |
| blood group | <haematology> An inherited feature on the surface of the red blood cell. A series of related blood groups make up a blood group system such as the ABO system or the Rh system. Erythrocytic allotypes (or phenotypes) defined by one or more cellular antigenic structural groupings under the control of allelic genes. Blood groups, especially for man, are identified by agglutinins supported by specific human or animal antisera and by lectins extracted from certain plants. See: blood group antigen. (25 Jun 1999) |
| blood group antigen | <haematology, immunology> The set of cell surface antigens found chiefly, but not solely, on blood cells. More than fifteen different blood group systems are recognised in humans. There may be naturally occurring antibodies without immunisation, especially in the case of the ABO system and matching blood groups is important for safe transfusion. In most cases the antigenic determinant resides in the carbohydrate chains of membrane glycoproteins or glycolipids. See: Rhesus, Duffy, Kell, Lewis and MN. (25 Jun 1999) |
| blood group incompatibility | A mismatch between donor and recipient blood. Antibodies present in the recipient's serum are directed against antigens in the donor product. Such a mismatch may result in a transfusion reaction in which, for example, donor blood is haemolyzed. (12 Dec 1998) |
| blood group substance | Blood group-specific substances A and B, solution of complexes of polysaccharides and amino acids that reduces the titre of anti-A and anti-B isoagglutinins in serum from group O persons; used to render group O blood reasonably safe for transfusion into persons of group A, B, or AB, but does not affect any incompatibility that results from various other factors, such as Rh. (05 Mar 2000) |
| CDE blood group | See Rh blood group, Blood Groups appendix. (05 Mar 2000) |
| p blood-group system | A blood group related to the abo, lewis and I systems. at least five different erythrocyte antigens are possible, some very rare, others almost universal. Multiple alleles are involved in this blood group. (12 Dec 1998) |
| Rhesus blood group | <haematology> Human blood group system with allelic red cell antigens C, D and E. The D antigen is the strongest. Red cells from a Rhesus positive foetus cross the placenta and can sensitise a Rehesus negative mother, expecially at parturition. The mother's antibody may then, in a subsequent pregnancy, cause haemolytic disease of the newborn if the foetus is Rhesus positive. The disease can be prevented by giving antiD IgG during the first 72 hours after parturition to mop up D red cells in the maternal circulation. 1st ed (18 Nov 1997) |
| rh-hr blood-group system | Erythrocyte isoantigens of the rh (rhesus) blood group system, the most complex of all human blood groups, because the genes differ by determining a different number of the over thirty antigens thus far described and do so with remarkably different quality. The major antigen rh or d is the most common cause of erythroblastosis foetalis. (12 Dec 1998) |
| MN blood group antigens | <haematology, immunology> A pair of blood group antigens governed by genes that segregate independently of the ABO locus. The alleles are codominant and there are three types MM, NN and MN. Glycophorin has M or N activity and this is associated with oligosaccharides attached to the amino terminal portion of the molecule. M type glycophorin differs from N type in amino acid residues 1 and 5, although the antigenic determinants are associated with the carbohydrate side chains. (18 Nov 1997) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|